DRD2 and schizophrenia: An example is the interaction of DISC1 with dopamine D2 receptors [61,62], or the DISC1-Kalirin-7 interaction that highlighted the potential of inhibitors, such as FRAX486, in preventing synaptic deterioration and improving behavioral deficits in schizophrenia models [63].